|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Distinction between papil- lary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 2 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-I显示文摘 | Lobse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 3 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immuno- histochemical staining for cytokeratin 19, galectin - 3, and HEME - 1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 4 | Early intervention in low-birth-weight premature infant:results through age 5 years from the Infant Health and Development Program显示文摘 | Brook Gunn Mc Carton CM Casey PH | 1994 | JAMA1994，272，16： | 1 |
| 5 | Relationship of subclinical thyroid disease to the incidence of gestational diabetes显示文摘 | Tudela CM Casey BM Mclntire DD | 2012 | Obstet Gynecol2012，119，5： | 1 |
| 6 | A meta-ana-lytic review of obesity prevention in the schools :1997-2008显示文摘 | COOK-COTTONE C CASEY CM FEELEY TH | 2009 | Psychol Sch2009，46，8： | 1 |
| 7 | Early intervention in low-birth-weight premature infants: results through age 5 years from the Infant Health and Development Program显示文摘 | Brooks-Gunn J McCarton CM Casey PH | 1994 | JAMA1994，272，： | 1 |
| 8 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-l显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 9 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19,galectin-3,and HBME-1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 10 | Distinction between papil-lary thyroid hyperplasia and papillary thyroid carcinoma byimmunohistochemical staining for cytokeratin 19,galectin-3 ,and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，： | 1 |
| 11 | A population-based study of cardiac malformations and outcomes associated with dextrocardia显示文摘 | Bohun CM Potts JE Casey BM | 2007 | Am J Cardiol2007，100，2： | 1 |
| 12 | Relationship of subclinical thyroid disease to the incidence of gestational diabetes显示文摘 | Tudela CM Casey BM Mclntire DD | 2012 | Obstet Gynecol2012，119，5： | 1 |
| 13 | Early intervention in low-birth-weight premature infant:results through age 5 years from the Infant Health and Development Program显示文摘 | Brook-Gunn J Mc Carton CM Casey PH | 1994 | JAMA1994，272，16： | 1 |
| 14 | Relationship of subclinical thyroid disease to the incidence of gestational diabetes 显示文摘 | Tudela CM Casey BM Mclntire DD | 2012 | Obstet Gynecol2012，119，： | 1 |
| 15 | Relationship of subclinical thyroid disease to the incidence of gestational diabetes显示文摘 | Tudela CM Casey BM Mclntire DD | 2012 | Obstet Gynecol2012，119，5： | 1 |
| 16 | Relationship of subclinical thyroid disease to the incidence of gestational diabetes显示文摘 | Tudela CM Casey CM Mclntire DD et a1 | 2012 | Obstet Gynecol2012，119，5： | 1 |
| 17 | Early intervention in low- birth - weight premature infants: results through age 5 years from the Infant Health and Development Program 显示文摘 | Brooks - Gunn J McCarton CM Casey PH | 1994 | JAMA1994，272，： | 1 |
| 18 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by inmunohistochemical staining for cytokeratin 19, galectin - 3, and HBMI- 1显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endoer Pathol2003，14，1： | 1 |
| 19 | Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1 显示文摘 | Casey MB Lohse CM Lloyd RV | 2003 | Endocr Pathol2003，14，1： | 1 |
| 20 | Relationship of subclinical thyroid disease to the incidence of gestational diabetes显示文摘 | Tudela CM Casey BM McIntire DD | 2012 | Obstet Gynecol2012，119，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员